Navigation Links
Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
Date:9/25/2007

TARRYTOWN, N.Y., Sept. 25 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) has agreed to accept $18 million from Eli Lilly and Company (NYSE: LLY) to settle the pending litigation between the two companies.

The parties will promptly submit a Stipulation of Dismissal with Prejudice of their litigation to the United States District Court for the Southern District of Indiana. Additional terms and conditions of the settlement are confidential. Emisphere will recognize the settlement net of attorneys' fees and expenses.

About Emisphere Technologies, Inc.

Emisphere Technologies, Inc. is a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical compounds using its eligen(R) technology. These molecules and compounds could be currently available or are in pre-clinical or clinical development. Such molecules or compounds usually cannot be delivered by the oral route of administration or the benefits of these compounds are limited due to poor bioavailability, slow on-set of action or variable absorption. The eligen(R) technology can be applied to the oral route of administration as well other delivery pathways, such as buccal, per rectum, pulmonary, intra-vaginal or transdermal. The Web site is: http://www.emisphere.com.

Safe Harbor Statement Regarding Forward-Looking Statements

The statements in this release and oral statemen
'/>"/>

SOURCE Emisphere Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Germantown drug company hires pharma veteran James Davidson as COO
2. Georgia stem cell company likely to stay put
3. Surgical products company wins Governors Business Plan Contest
4. Madison stem cell company gets $1M from state
5. Company still behind schedule on Milwaukee wireless project
6. Software company enters health space with RFID solutions on hold
7. Delaware company will keep NameProtect here
8. IPO-bound NimbleGen traveling in fast company
9. Wisconsin tries to woo another stem cell company
10. Company to operate in wireless Internet space
11. RedPrairie acquires Denver software company

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...tCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:...ced updated results from a Phase II study of intra...tatic to the lung in a poster presentation at the ...ting held in Miami Beach, Florida, from November 5...ase II Study of Intravenous REOLYSIN (Wild-type Re...
(Date:11/5/2009)...swire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) ...d quarter ended September 30, 2009. GenVec reporte... the three months ended September 30, 2009 compare...in the comparable quarter of 2008. For the nine mo...as $14.1 million ($0.15 per share), compared to a ...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasd...ucts for processing and storing adult stem cells, ...scal 2010. ,, For the quarter ended September 3...lion, a 15 percent increase over revenues of $4.5 ...ny said the key contributors to the growth in reve...
(Date:11/5/2009)...swire-FirstCall/ -- Cepheid (Nasdaq: CPHD ) today... the following investor conferences, and invited i... Credit Suisse Healthcare Conference, Phoeni... at 10 a.m. Mountain Time, NASDAQ... Tuesday, 1 December, 2009 at 10.45 a.m....
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2
...,s Lawrence Berkeley National Laboratory and the U...he world,s first all-integrated sensor circuit bas... electronics made of different crystalline materia... such devices with high uniformity. , Nanostruct...other properties have a number of advantages over ...
.... (Nasdaq: CADX ), a biopharmaceutical company fo...ng proprietary product candidates principally,for ...the company,s,President and CEO Theodore Schroeder...the following investment conferences:, -- Bank o...nce at the Southampton Inn, Long Island, New Y...
...% from Same Prior Year Period, DUBLIN, Calif., Au...tical company dedicated to the discovery, rapid,de...olid tumors and,hematological malignancies, today ... and six months ended June 30, 2008., Total reven... compared,with $4.6 million for the same prior yea...
Other Biology Technology:A first in integrated nanowire sensor circuitry 2A first in integrated nanowire sensor circuitry 3A first in integrated nanowire sensor circuitry 4Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008 2SuperGen Reports 2008 Second Quarter Financial Results 2SuperGen Reports 2008 Second Quarter Financial Results 3SuperGen Reports 2008 Second Quarter Financial Results 4SuperGen Reports 2008 Second Quarter Financial Results 5SuperGen Reports 2008 Second Quarter Financial Results 6SuperGen Reports 2008 Second Quarter Financial Results 7SuperGen Reports 2008 Second Quarter Financial Results 8SuperGen Reports 2008 Second Quarter Financial Results 9SuperGen Reports 2008 Second Quarter Financial Results 10SuperGen Reports 2008 Second Quarter Financial Results 11SuperGen Reports 2008 Second Quarter Financial Results 12SuperGen Reports 2008 Second Quarter Financial Results 13
(Date:11/4/2009)...fic corridors in the cities of Long Beach and Rive... of preventable childhood asthma, and the true imp...ease has likely been underestimated, according to ...ia (USC). , The study, which appears in an onli...th , estimated that nine percent of all childhood ...
(Date:11/4/2009)... BC - Lowly bacteria, it turns out, hold the power...ants around the world clean up toxic waste on test...cally RDX, were invented back in World War II and ... These high-energy compounds are often used to pro...on of TNT. , But with increased knowledge of t...
(Date:11/4/2009)...sity of Oklahoma at Norman has received more than ...gencies as part of the federal stimulus program, b...ed by OU researchers to $23 million. Thirty-three...nging from archaeology to weather. , "The univer...oach to matching areasof scholarly excellence to f...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2Genomic research will enable greener cleanup of military explosive test sites 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Former Associates File Suit Against Univera 3A Dietary Supplement Company Accused of Intimidation Bullying and Unfair Trade Practices 50104 1Former Associates File Suit Against Univera 3A Dietary Supplement Company Accused of Intimidation Bullying and Unfair Trade Practices 50104 2Cell Protein Could Help Spur Malignancy 50101 1Cell Protein Could Help Spur Malignancy 50101 2Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 1Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 2Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 3Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 4
...OLIS / ST. PAUL (Jan. 8, 2008) Adolescent girls w... less likely to use diet pills, laxatives, or othe...ars later, according to research led by Dianne Neu...tor of Project Eating Among Teens (Project EAT) at...th. , Neumark-Sztainer and Project EAT colleagues...
...lphia, PA, January 8, 2008 Schizophrenia is a dev... contributing to increased risk. Available antips...schizophrenia, but are typically effective in only...cult to predict the effectiveness of a specific dr...hn H. Krystal, M.D., Editor of Biological Psychiat...
...ter Joins Olive, Edwards & Cooper with Technical, ...ound, WASHINGTON, Jan. 7 Today, Olive, Edwards &...ter as a principal who will,provide clients with s...meland security marketplace. His immediate focus w...dgeable about the SAFETY Act (the Support,Anti-Ter...
Other Biology News:U of M research finds disordered eating less common among teen girls who regularly eat family meals 2Genetic variant predicts antipsychotic response for schizophrenia patients by ethnicity 2Chemist Brings SAFETY Act Expertise to Homeland Security Firm 2
Wellpro 384 from Thermo Scientific
Clamps from Thermo Scientific
Scotch-Brite pads from Thermo Scientific
Multidrop DW (Deep Well) (220-240 V) from Thermo Scientific
Biology Products: